DE60216287D1 - Lyophilisierende zusammensetzung von wirkstoff-verkapselnder polymer-mizelle und verfahren zu ihrer herstellung - Google Patents

Lyophilisierende zusammensetzung von wirkstoff-verkapselnder polymer-mizelle und verfahren zu ihrer herstellung

Info

Publication number
DE60216287D1
DE60216287D1 DE60216287T DE60216287T DE60216287D1 DE 60216287 D1 DE60216287 D1 DE 60216287D1 DE 60216287 T DE60216287 T DE 60216287T DE 60216287 T DE60216287 T DE 60216287T DE 60216287 D1 DE60216287 D1 DE 60216287D1
Authority
DE
Germany
Prior art keywords
polymer
preparing
micres
capsulating
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60216287T
Other languages
English (en)
Other versions
DE60216287T2 (de
Inventor
Yasuaki Ogawa
Shoko Nagasaki
Yoshihiko Nogata
Katsuhiko Sagawa
Chieko Tsuchiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NanoCarrier Co Ltd
Original Assignee
NanoCarrier Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2001213652A external-priority patent/JP3615721B2/ja
Priority claimed from JP2001213617A external-priority patent/JP4063510B2/ja
Application filed by NanoCarrier Co Ltd filed Critical NanoCarrier Co Ltd
Application granted granted Critical
Publication of DE60216287D1 publication Critical patent/DE60216287D1/de
Publication of DE60216287T2 publication Critical patent/DE60216287T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60216287T 2001-07-13 2002-07-12 Lyophilisierende zusammensetzung von wirkstoff-verkapselnder polymer-mizelle und verfahren zu ihrer herstellung Expired - Lifetime DE60216287T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001213617 2001-07-13
JP2001213652A JP3615721B2 (ja) 2001-07-13 2001-07-13 薬物含有高分子ミセルの製造方法
JP2001213617A JP4063510B2 (ja) 2001-07-13 2001-07-13 薬物含有高分子ミセルの凍結乾燥用組成物およびその凍結乾燥製剤
JP2001213652 2001-07-13
PCT/JP2002/007099 WO2003005992A1 (en) 2001-07-13 2002-07-12 Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof

Publications (2)

Publication Number Publication Date
DE60216287D1 true DE60216287D1 (de) 2007-01-04
DE60216287T2 DE60216287T2 (de) 2007-05-31

Family

ID=26618693

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60216287T Expired - Lifetime DE60216287T2 (de) 2001-07-13 2002-07-12 Lyophilisierende zusammensetzung von wirkstoff-verkapselnder polymer-mizelle und verfahren zu ihrer herstellung

Country Status (8)

Country Link
US (3) US20040253315A1 (de)
EP (1) EP1415648B1 (de)
KR (1) KR100776557B1 (de)
CN (1) CN1268321C (de)
AT (1) ATE345780T1 (de)
CA (1) CA2453441C (de)
DE (1) DE60216287T2 (de)
WO (1) WO2003005992A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050152979A1 (en) * 2003-09-05 2005-07-14 Cell Therapeutics, Inc. Hydrophobic drug compositions containing reconstitution enhancer
WO2006057429A1 (ja) * 2004-11-24 2006-06-01 Nanocarrier Co., Ltd. ブロックコポリマーのモーフォロジ－の変化方法
US7829657B2 (en) * 2005-02-10 2010-11-09 The University Of Tokyo Polycationically charged polymer and the use of the same as a carrier for nucleic acid
US7612139B2 (en) 2005-05-20 2009-11-03 E.I. Du Pont De Nemours And Company Core/shell fluoropolymer dispersions with low fluorosurfactant content
KR100917809B1 (ko) * 2006-05-22 2009-09-18 에스케이케미칼주식회사 우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
AR063330A1 (es) * 2006-10-20 2009-01-21 Solvay Pharm Bv Nanoparticulas micelares incrustadas
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
US20090232762A1 (en) * 2008-03-11 2009-09-17 May Pang Xiong Compositions for delivery of therapeutic agents
US8697098B2 (en) 2011-02-25 2014-04-15 South Dakota State University Polymer conjugated protein micelles
EP2287230B1 (de) * 2008-05-23 2012-09-26 NanoCarrier Co., Ltd. Docetaxelpolymerderivat, Verfahren zu seiner Herstellung und Verwendung
US20150359777A1 (en) * 2008-12-26 2015-12-17 Samyang Biopharmaceuticals Corporation Preparation method of polymeric micellar nanoparticles composition containing a poorly water-soluble drug
AU2009331027B2 (en) * 2008-12-26 2012-12-13 Samyang Holdings Corporation Preparation method of polymeric micellar nanoparticles composition containing a poorly water-soluble drug
US20100310660A1 (en) * 2009-06-08 2010-12-09 Taipei Medical University Dry powder microparticles for pulmonary delivery
EP3150194A1 (de) * 2009-08-31 2017-04-05 NanoCarrier Co., Ltd. Partikelzusammensetzung und medizinische zusammensetzung damit
JP4653242B1 (ja) 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物
KR20130087517A (ko) 2010-06-25 2013-08-06 백시바디 에이에스 동종이합체 단백질 구조물
CN103945830B (zh) 2011-02-25 2017-06-06 南达科他州立大学 缀合蛋白的聚合物胶束
KR101038563B1 (ko) * 2011-04-12 2011-06-02 주식회사 세종전력기술단 분배전반용 캐비넷
CN102526756A (zh) * 2012-02-15 2012-07-04 中国科学院长春应用化学研究所 阿霉素复合物、胶束及胶束的制备方法
KR101801566B1 (ko) 2014-12-30 2017-11-28 주식회사 삼양바이오팜 고분자 나노입자 동결건조물 및 그 제조방법
KR102072419B1 (ko) 2018-04-19 2020-02-03 중앙대학교 산학협력단 항암제 봉입 마이셀 제제 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1264162A (en) * 1984-03-15 1990-01-02 Manfred Breuninger Glycerol ether phosphatides
FR2618258B1 (fr) * 1987-07-17 1990-01-05 Suisse Electronique Microtech Detecteur de particules ionisantes.
JP2517760B2 (ja) * 1989-05-11 1996-07-24 新技術事業団 水溶性高分子化医薬製剤
JP2780116B2 (ja) * 1989-07-31 1998-07-30 日水製薬株式会社 リポソーム分散液安定化剤
ES2138588T3 (es) * 1990-06-29 2000-01-16 Chiron Corp Composiciones de vacunas que contienen liposomas.
EP0619730B1 (de) * 1992-10-08 2000-12-27 Supratek Pharma Inc. Zusammensetzung von in mizellen eingeschlossenen antineoplastischen wirkstoffen
US5552156A (en) * 1992-10-23 1996-09-03 Ohio State University Liposomal and micellular stabilization of camptothecin drugs
US5543158A (en) * 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
JPH07249723A (ja) * 1994-03-11 1995-09-26 Fujitsu Miyagi Electron:Kk 半導体装置の実装構造及び半導体装置の実装方法及びリードフレーム
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
JPH11335267A (ja) * 1998-05-27 1999-12-07 Nano Career Kk 水難溶性薬物を含有するポリマーミセル系
AU776782C (en) * 1999-03-03 2005-04-07 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
CN1156269C (zh) * 1999-07-16 2004-07-07 阿尔萨公司 抗冻/融损害的脂质体组合物
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
JP4659937B2 (ja) * 1999-11-19 2011-03-30 ナノキャリア株式会社 コア−シェル構造のポリイオンコンプレックスミセル

Also Published As

Publication number Publication date
KR20040018432A (ko) 2004-03-03
DE60216287T2 (de) 2007-05-31
KR100776557B1 (ko) 2007-11-16
CA2453441C (en) 2011-10-18
EP1415648A1 (de) 2004-05-06
CN1268321C (zh) 2006-08-09
US20140141072A1 (en) 2014-05-22
CA2453441A1 (en) 2003-01-23
US20040253315A1 (en) 2004-12-16
ATE345780T1 (de) 2006-12-15
EP1415648B1 (de) 2006-11-22
CN1543340A (zh) 2004-11-03
EP1415648A4 (de) 2006-01-18
WO2003005992A1 (en) 2003-01-23
US20120141556A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
DE60216287D1 (de) Lyophilisierende zusammensetzung von wirkstoff-verkapselnder polymer-mizelle und verfahren zu ihrer herstellung
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
DE60124929D1 (de) Elastomerische, funktionelle, bioabbaubare copolyesteramide und copolyesterurethane
ATE263782T1 (de) Verfahren zur herstellung von il-1ra, einem therapeutisch wirksamen protein, aus körperflüssigkeiten
PT983087E (pt) Composicao de vacina multivalente com veiculo misto
DE69932648D1 (de) Verdickend wirkendes Latex, Verfahren zu dessen Herstellung und Anwendungen in der Kosmetik
ATE333464T1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika
ATE410441T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen
FR2841900B1 (fr) Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations
CA2449244A1 (en) Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug
DE69524977D1 (de) Lösliche, elektroleitfähige polypyrrole und verfahren zur herstellung
ATE285754T1 (de) Pharmazeutische zusammensetzung mit lyophilisierten lyposomen welche einen unlöslichen aktiven wirkstoff einschliessen, verfahren zu dessen herstellung
DE69530844D1 (de) Verfahren und substanzen gegen protozoen
DE60214035D1 (de) Olefinisches thermoplastisches elastomer, verfahren zu seiner herstellung, olefinisches thermoplastisches elastomer enthaltende zusammensetzungen, verfahren zu ihrer herstellung und formkörper daraus
NO20073914L (no) Biologisk aktive peptider
DE60034885D1 (de) Enzymlauge und verfahren zu deren herstellung, enzymzubereitung, proteasezubereitungen und proteaseproduzierendes bakterium
HK1046648A1 (en) Vaccines containing hybrid polypeptides consistingof at least two different allergenic proteins
EP0853944A3 (de) Präparation umfassend Thiolgruppen-hältige Proteine
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
WO2000032629A3 (en) Antiviral peptides
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
DE69804302D1 (de) Kationische mittel zur transfektion von nukleinsäuren
ATE250578T1 (de) Indenoindolon-derivate, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen
WO2001066709A3 (en) Sphingomyelinase enzymes and uses relating thereto
TR199700109A2 (tr) Sübstitüe edilmis olan tiofenilalkenil karbonik asit guanidid'leri, bunlarin üretilmesine mahsus usul, bunlarin ilac veya diyagnostik olarak kullanilmalari ve bunlari iceren ilac.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition